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Abstract
The structures, obtained by X-ray crystallography, of the
binding sites of catalytic antibodies raised to bind different
phosphonates are compared. Although the amino acid sequences
differ, all exhibit a tetrahedral array of hydrogen bond donors (a
‘canonical binding array’) complementary to the tetrahedral
anion, which represents a ‘transition state epitope’ for the basic
hydrolysis of esters and amides. Antibodies for phosphates,
arsonates, and sulfonates are found also to possess the tetrahedral
anion canonical binding array. ß 2001 Elsevier Science Ltd. All
rights reserved.
Keywords: Canonical binding array; Molecular recognition; Immune sys-
tem; Tetrahedral anion
1. Introduction
The ability of the immune system to produce proteins
that selectively bind to almost any foreign antigen is amaz-
ing. It is known that the immune system possesses a naive
repertoire of greater than 108 antibody binding sites (de-
rived from only 103^104 gene fragments) in the absence of
antigen [1]. When the immune system is challenged by an
antigen, the process of a⁄nity maturation produces new
antibodies that bind to antigens with increased a⁄nity and
speci¢city [2].
Following a strategy suggested by Jencks [3], antibody
catalysts [4^11] for many organic reactions have been pro-
duced by challenging the immune system with stable
mimics [12] of putative transition states. Since the mature
antibodies produced in this manner bind to transition state
analogs (TSAs), catalysis is often achieved through selec-
tive stabilization of a transition state over other species on
the reaction’s potential energy surface. Even in cases that
do not strictly conform to this paradigm, transition state
complementarity is responsible for some fraction of catal-
ysis, and recent computational studies on antibody-cata-
lyzed reactions have revealed intimate details of antibody^
transition state interactions [13^24].
Catalysis requires selective binding of the transition
state. Modi¢cations of the TSA should cause a change
in the binding site and attenuation of the catalyst pro¢-
ciency. We have explored the structures of 10 catalytic
antibodies for ester and amide hydrolysis and have com-
pared these to antibodies that bind phosphonates, arso-
nates, and sulfonates. We have found that the immune
system binds all of these tetrahedral anions by a recurring
motif that we refer to as a ‘canonical binding array’. The
implications for production of antibody catalysts are dis-
cussed.
2. Results and discussion
2.1. Binding sites for tetrahedral anionic haptens
The majority of all known catalytic antibodies hydro-
lyze esters or amides or mediate closely related reactions
such as transesteri¢cation or ester aminolysis [4^11]. As a
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result, much of our understanding of how antibodies cat-
alyze chemical reactions has been derived from experi-
ments on hydrolysis.
X-ray structures of greater than 10 hydrolytic antibodies
have been described in the literature [25^60]. The haptens
used to elicit these antibodies are shown in Table 1, along
with kinetic data on catalysis and some information about
the X-ray structures. All of the haptens are aryl or benzyl
phosphonate or phosphonamidate TSAs and were conju-
gated to bovine serum albumin (BSA) or keyhole limpet
hemocyanin carrier proteins during immunization. Fig. 1
shows the binding sites for these antibodies. Hapten bind-
ing involves recognition of the anionic phosphonate oxy-
gens by several hydrogen bond donating residues and se-
questration of the aromatic moiety in a hydrophobic
pocket (Fig. 1). It was suggested in 1996 by MacBeath
and Hilvert that the combining sites of four of these in-
dependently derived antibodies ^ 48G7 [25^29], CNJ206
[30^33], 17E8 [34^42], and 43C9 (at the time only available
in a modeled structure based on the sequence) [43^51] ^
represent ‘variations on a theme’ which may be general for
antibody-catalyzed hydrolysis [61] based on sequence anal-
ysis and the observation that many of the same residues
were found to contact bound hapten in 48G7, CNJ206,
and 17E8 (Fig. 1). Subsequent structures of the germline
precursor to 48G7 [25^29] and another antibody from the
same immunization as 17E8, 29G11 [34^42], show similar
patterns of hapten recognition (Fig. 1). In Fig. 1, we em-
phasize relative orientations of the four or more hydrogen
bond donors observed to contact the anionic oxygens of
the phosphonate haptens.
At the time of the ‘variations’ proposal [61], the X-ray
structure of 43C9 was not available. The structure of this
antibody complexed with para-nitrophenol was, however,
reported recently [51]. Although the hapten (a phosphona-
midate), substrate (an amide), and mechanism of catalysis
(thought to involve the formation of a covalent adduct)
di¡er from those of 48G7, CNJ206, 17E8, and their rela-
Table 1
Haptens and substrates for structurally characterized hydrolytic antibodiesa
aReferences may be found in the text. PNPOH refers to para-nitrophenol.
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tives, the binding site of 43C9 does indeed show a similar
pattern of residues involved in hapten recognition (Fig. 1).
Crystal structures of additional hydrolytic antibodies
(D2.3, D2.4, and D2.5) [52^55] show that the ‘variations’
proposal can be extended to benzyl phosphonate recogni-
tion as well [62]. The pockets in D2.3, D2.4, and D2.5 are
slightly more spacious than those of the ‘variations’ anti-
bodies ^ most likely due to the fact that they were elicited
against benzyl rather than aryl phosphonate haptens ^ and
hapten recognition is mediated by water molecules in sev-
eral places. Nonetheless, antibodies D2.3, D2.4, and D2.5
do possess binding sites which are similar to those ob-
served for CNJ206, 48G7 and 17E8 (Fig. 1).
The similarity of these binding sites can be assessed in
several ways: in terms of the binding surface presented by
the antibody and in terms of the actual residues that con-
tact the bound hapten. Fig. 2 provides a comparison of
combining site residues from the former perspective. It is
clear from this sort of comparison that combining sites
elicited against similar phosphonate haptens contain
many similar ^ often identical ^ residues at particular po-
sitions. All of these antibodies have His35H at site a and a
tyrosine residue at site c (Figs. 1 and 2). The residues at
sites b and d are more variable, yet still somewhat con-
served.
Fig. 3 delineates the types of contacts actually found for
the pro-R and pro-S oxygen atoms of the haptens. In this
¢gure the residues are grouped according to their position
Fig. 1. Crystallographically determined binding sites of hydrolytic antibodies. Bound hapten (Table 1) is shown in each case, except for 43C9 where
only the para-nitrophenol-bound structure was available; in this structure, the two water molecules shown are presumed to be located in approximately
the same areas as the phosphonamidate oxygens would be. Residues that hydrogen bond to phosphonate oxygens are labeled in red. In the 17E8 and
29G11 structures, the orientation of the imidazole ring of His35H has been £ipped by 180‡ from that reported.
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relative to the hapten oxygens rather than in sequence (as
in Fig. 2). There is clearly greater similarity in the type of
hydrogen bond donor presented to the hapten than in the
speci¢c identity of the residue that provides it, and in
several cases the actual hydrogen bond donor is an ori-
ented water molecule.
Recently, X-ray structures of two hydrolytic antibodies
from another family (6D9 and 7C8) have cast some doubt
on the generality of the phosphonate binding ‘theme’ [56^
60]. These crystal structures (see Fig. 4) show that the
benzyl phosphonate hapten used to elicit 6D9 and 7C8
(Table 1) does not bind in the same type of binding pocket
used to bind the other aryl and benzyl phosphonate hapt-
ens. In addition, the hapten binds in di¡erent orientations
in 6D9 and 7C8. These observations suggest that the bind-
ing site theme is limited to antibodies derived from rela-
tively unsubstituted aryl and benzyl phosphonate haptens.
The additional functionality present in the hapten used to
elicit 6D9 and 7C8 (Table 1) comprises as much of its
structure as does the benzyl phosphonate substructure,
and therefore the antibody repertoire is presented with
many additional recognition elements upon immunization
Fig. 2. Residues that line the phosphonate binding site. Site (a) corre-
sponds to the residue at position 35H in all antibodies. Site (b) corre-
sponds to the residue at position 96L in all antibodies. Site (c) corre-
sponds to a residue in the vicinity of position 100H. Site (d)
corresponds to a residue in the vicinity of position 33H or 95H. See
Fig. 1 for the crystallographically determined positions of all residues.
The most common residues at each site are colored red and blue.
Fig. 3. Antibody residues that donate hydrogen bonds to oxygen atoms
of the haptens. The residues are grouped into four groups (di¡erent
from those in Fig. 2) based on their spatial relationships with the pro-R
and pro-S oxygen atoms of the phosphonate haptens. See Fig. 1 for
crystallographically determined positions of all residues. The residues
are color-coded based on the type of hydrogen bond donor that they
present to the hapten.
Fig. 4. Crystallographically determined binding sites of hydrolytic antibodies 6D9 and 7C8. Bound hapten (Table 1) is shown for 7C8, and a modi¢ed
hapten, in which one phosphonate oxygen is replaced by a substituted nitrogen, is shown for 6D9.
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with this hapten. In other words, the 6D9 and 7C8 hapten
appears to sport multiple epitopes, analogous to the sit-
uation usually observed for much larger antigens such as
proteins. Nonetheless, the similarities between many of the
hydrolytic antibodies are striking when the hapten has an
exposed tetrahedral anion.
While the naive repertoire of antibodies possesses a few
very similar binding sites suitable for recognition of phos-
phonate groups [21,25], these binding sites are not limited
to phosphonate recognition.
A database search (Tantillo, D.J. and Houk, K.N., un-
published results) has revealed that several antibodies
raised against para-azophenylarsonate-derivatized (Fig. 5)
carrier proteins have very similar variable region sequen-
ces ^ and related germline precursors ^ to those of the
phosphonate binders [30,63^65]. For example, light and
heavy chain variable region sequences of the anti-arsonate
antibodies 123E6, 124E1, 93G7, 91A3, 36-71 and 2F19
exhibit 67^80% identity to those of hydrolytic antibody
17E8. While the complementarity determining regions
(CDRs) of the anti-arsonate antibodies di¡er from those
of 17E8 at many sites, these di¡erences are often conser-
vative. In particular, hydrogen bond donor functionalities
are maintained in these regions as would be expected for
stabilization of the negative charge which should be dis-
tributed similarly over the phosphonate and arsonate
groups. Several X-ray crystal structures of anti-arsonate
antibodies have also been reported, albeit without haptens
bound. The structures of the proposed hapten binding
sites of antibodies 36-71 and 2F19 are shown in Fig. 5
[63^65]. These binding sites are extremely similar to those
of hydrolytic antibodies (Fig. 1), containing, for example,
the highly conserved Arg96L and replacing His35H of the
phosphonate binders with the similar hydrogen bond do-
nor Asn35H (see Fig. 2) [26].
Several anti-DNA antibodies [66] also have sequences
similar to those of hydrolytic antibodies. In particular,
the light chain variable regions of anti-DNA antibodies
DP7 and DP11 are extremely similar to those of 48G7
(nearly 90% identity! V60% identity to the 48G7 heavy
chain variable region). Again many di¡erences appear to
be conservative, but without three-dimensional structures
of these antibodies, binding site similarities remain spec-
ulative at best [30,51,67,68].
It should perhaps be expected that arsonate haptens and
nucleic acids will elicit antibodies similar to those elicited
in response to phosphonate haptens. Arsonate and phos-
phonate groups are obviously geometrically and electroni-
cally similar. It is also likely that anti-nucleic acid anti-
bodies recognize the phosphodiester groups of the
polyphosphate backbone which resemble the phosphonate
groups present in the haptens, although DNA binding is
most likely dominated by surface^surface interactions
[67,68].
Recently, a crystal structure of antibody 21D8, an anti-
body decarboxylase, has also become available [21]. This
Fig. 5. Structures of the putative hapten binding sites of antibodies 36-71 and 2F19.
Fig. 6. The decarboxylation reaction catalyzed by antibody 21D8, the naphthalene disulfonate hapten used to elicit 21D8, and the 21D8 binding site.
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antibody catalyzes the decarboxylation of carboxybenzi-
soxazoles (Fig. 6), a reaction that clearly di¡ers from ester
hydrolysis. Antibody 21D8 was raised against a naphtha-
lene disulfonate hapten (Fig. 6). The combining site of this
antibody is extremely similar to that of the hydrolytic anti-
bodies discussed above (compare Figs. 1 and 6) ^ espe-
cially that of 48G7 [21]. It is likely that this similarity is
due to the fact that the haptens used to elicit both 21D8
and 48G7 contain tetrahedral anionic groups (phospho-
nates or sulfonates) connected to planar aromatic moi-
eties. The similarity of 21D8 and 48G7 suggests that
they may cross-react, and computational docking studies
(Tantillo, D.J. and Houk, K.N., unpublished results) in-
dicate that 21D8 should be able to bind the transition
state for hydrolysis of para-nitrophenyl esters [69] and
provide catalysis.
2.2. Transition state epitopes (TSEs) and canonical binding
arrays
The similarities in both sequence and structure between
this diverse group of antibodies are perhaps best explained
by the presence of generic germline binders for tetrahedral
anions connected to aromatic rings (Fig. 7). These func-
tional groups together comprise an example of what we
refer to as a TSE: the key recognition elements present in
the transition state (and TSAs) for an antibody-catalyzed
reaction. We de¢ne the binding motif shared by these
germline antibodies ^ several key hydrogen bond donating
residues oriented to speci¢cally stabilize tetrahedrally dis-
played anionic heteroatoms coupled to a nearby hydro-
phobic pocket ^ as a ‘canonical binding array’ in the spirit
of the canonical combinations of V gene segments of
Manser and coworkers [70] and the canonical CDR classes
of Chothia and Lesk [71]. A correlation has been observed
previously between the combination of canonical classes
used to bind an antigen and the type of antigen (protein,
polysaccharide, nucleic acid, hapten, etc.) bound [72,73],
and this correlation is now extended to amino acid side-
chain functionalities as well. Interestingly, the canonical
array concept was foreshadowed by Wu and Kabat who
noted over 30 years ago that ‘a mixture of structurally
di¡erent antibody molecules (i.e. belonging to di¡erent
immunoglobulin classes or subclasses) could have the
same binding a⁄nity and therefore probably have very
similar or even identical combining sites’ [74].
2.3. Biological epitope mimicry
The function of antibody binding sites is to bind frag-
ments of common biomolecules such as proteins, carbohy-
drates, and nucleic acids that are signatures of foreign
organisms. Generation of antibody catalysts may therefore
be most e¡ective when transition states and their analogs
Fig. 7. Antibody ligands that share the TSE (shown in red and described at the bottom of the ¢gure) and that are bound by the ‘canonical array’
described in the text: phosphonates and derivatives, transition states for hydroxide attack on aryl esters, para-azophenylarsonate, nucleotides, and a
naphthalene disulfonate hapten.
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resemble naturally occurring biological molecules. In this
scenario, mature binding sites that are complementary to
transition states for non-biological reactions are derived
from germline binding sites that are complementary to
biological epitopes. Phosphate and phosphodiester groups
of nucleic acids are biological epitopes which are mim-
icked [75,76] by phosphonate, sulfonate, and arsonate
haptens. Interestingly, some of the most e⁄cient antibody
catalysts known were raised against phosphonate TSA 1
(Scheme 1) and promote the transesteri¢cation reaction
shown in Scheme 1 to produce the corresponding ester 2
with (kcat/Km)/kuncat values of approximately 108 and ef-
fective molarities (kcat/kuncat) of approximately 105 [77^79].
The similarity of hapten 1 to thymine dinucleotide is ob-
vious.
Evidence exists for other cases of biological epitope
mimicry as well. The three-dimensional structures of two
antibodies, 39-A11 and 1E9, that catalyze Diels^Alder re-
actions have recently been determined to high resolution
[14,80]. Stevens and Schultz [80] have noted the similarity
in structure between 39-A11 and two other structurally
related antibodies, DB3 and TE33, and Houk, Hilvert,
and Wilson [14] have discussed the relationships between
39-A11, DB3, and 1E9 in detail. Antibody TE33 binds the
15-residue cholera toxin peptide [81,82], which contains a
type II L-turn when bound, and DB3 binds steroids such
as progesterone [80,83^85]. The L-turn structure of cholera
toxin has been shown to bind in a pocket similar to those
that bind progesterone and the bicyclic ring systems of
TSA haptens 3 and 4 used to elicit 39-A11 and 1E9, re-
spectively (Chart 1). The valine^proline^glycine sequence
involved in the L-turn and the hydrocarbon rings of the
haptens and steroids have all led to antibody hosts which
contain deep hydrophobic pockets. Since type II L-turns
often contain hydrophobic proline and glycine residues for
geometric reasons [86], a deep hydrophobic pocket would
seem ideal as a generic binding site for these structures. It
is therefore plausible that generic L-turn binders in the
naive repertoire have led to TE33, DB3, 39-A11, and
1E9, and the connections between the germline precursors
to these antibodies have been noted [14,80]. This is an
elegantly simple case of biological epitope mimicry in
which a host for a biological hydrophobic array has led
to catalysts for reactions that proceed through non-polar
transition states.
2.4. A⁄nity maturation and the development of speci¢city
The fact that the binding sites of antibodies 39-A11,
1E9, TE33, and DB3 are similar does not necessarily
mean that they will cross-react. While DB3 successfully
binds many di¡erent steroids [83^85], it does not acceler-
ate the Diels^Alder reaction promoted by 1E9 to any ap-
preciable extent [14]. Moreover, when screened against a
Chart 1.
Scheme 1.
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‘panel of 72 structurally diverse hapten^BSA conjugates’,
the germline precursor to 39-A11 displayed broad cross-
reactivity, while no cross-reactivity was observed for 39-
A11, suggesting that germline ‘polyspeci¢city is tempered
upon a⁄nity maturation’ [80]. These results emphasize
that the alterations to antibody combining sites that occur
upon maturation, while often structurally subtle, can have
considerable consequences for cross-reactivity.
A similar loss of polyspeci¢city upon maturation has
been reported for anti-arsonate antibodies [70]. It was ob-
served that antibodies isolated from early in the primary
immune response to para-azophenylarsonate conjugates
bind single stranded DNA (the similarities between anti-
arsonate, anti-DNA, and hydrolytic antibodies were dis-
cussed above). Antibodies isolated during the secondary
immune response, however, lacked this polyspeci¢city.
An elegant study of hydrolytic antibody 48G7 by
Schultz and Stevens [25^29], in which this antibody and
its germline precursor were characterized both biochemi-
cally and structurally, provides great insights into the
chemical details of a⁄nity maturation. Mature 48G7 and
its germline precursor di¡er by only nine mutations; these
increase the a⁄nity for hapten (a phosphonate TSA, Table
1) by a factor of 104 and the rate of hydrolysis by a factor
of 102 [26,27]. None of the nine mutated residues actually
contacts the hapten, but these mutations in£uence details
of the combining site structure by causing subtle reorien-
tations of combining site functionalities (Fig. 1).
In light of experiments such as these which show that
a⁄nity maturation proceeds with relatively few mutations,
much of a mature antibody’s ability to bind a substrate
must be encoded by the germline. The a⁄nity maturation
process tends to tighten binding through relatively few and
distant mutations [25^29,87], suggesting that the initial
recognition events in the immune response need only to
involve relatively loose binding. The ability of the immune
response to produce antibody catalysts is most likely a
result of the fact that TSAs (and transition states them-
selves) happen to ¢t into generic germline sites reasonably
well.
If antibodies adopt multiple conformations [88^90], the
diversity of the naive repertoire is greatly increased [91]. In
fact, it has been observed in several cases that conforma-
tional changes upon binding in di¡erent antibodies lead to
similar combining sites. This is an unusual and unexpected
type of structural convergence.
In the case of hydrolytic antibodies D2.3, D2.4, and
D2.5, crystal structure analysis did not reveal any signi¢-
cant conformational changes upon hapten binding [52^54].
However, subsequent kinetic experiments revealed that a
pre-equilibrium exists for each of these antibodies that
converts between active and inactive conformers. This
equilibrium is shifted towards the active conformer in
the presence of hapten [55], and it is the active conformer
of each that displays the canonical binding array. It was
estimated that this conformational change leads to a 30^
170-fold increase in a⁄nity for hapten. This situation sug-
gests that the pressure of hapten binding can select for
£exible antibodies capable of obtaining productive confor-
mations in addition to those that are rigidly preorganized
for binding.
The convergence of hydrolytic catalyst structures from
di¡erent immunizations with di¡erent haptens was dis-
cussed above [61,62]. In the case of antibody CNJ206, a
drastically di¡erent antibody conformation was observed
in the X-ray structures of free and hapten-bound antibody
[30^33], an observation that is consistent with a conforma-
tional change upon binding [32]. Again the canonical ar-
ray was not necessarily preorganized in solution, but was
selected for in the presence of hapten.
A similar situation has been reported for antibodies to
foot-and-mouth disease virus [92]. Crystal structures of
two di¡erent antibodies ^ complexed to their peptide anti-
gens and antigen-free ^ showed that conformational
changes upon antigen binding lead to a situation in which
‘the two Fab fragments are closer in structure in the com-
plexes than in the unbound state’ [92].
The extra diversity a¡orded the immune system by con-
formational £exibility is likely to be most signi¢cant in the
naive repertoire. Based on their crystallographic studies,
Schultz and Stevens suggested that the conformational
£exibility of hydrolytic antibody 48G7 is considerably
less than that of its germline precursor [25^29], and recent
molecular dynamics calculations by Kollman and cowork-
ers support this hypothesis [93].
The blind versatility of the immune system also often
leads to combining site functionalities that can interact
favorably with elements of transition states not captured
by TSA haptens. Automated docking of quantum me-
chanical transition states into antibody structures has pro-
vided insights into catalysis by pinpointing speci¢c non-
covalent interactions between transition states and anti-
body combining sites [14^24]. In the case of hydrolytic
antibodies 48G7, CNJ206, 17E8 and 29G11, this type of
analysis (Tantillo, D.J. and Houk, K.N., unpublished re-
sults) revealed that one of two possible enantiomeric path-
ways for reaction (si and re attack of hydroxide ion on
aryl esters) is often heavily favored in antibody combining
sites despite their selection for tight binding to symmetri-
cal haptens. This selectivity arises from the inherent asym-
metry of binding sites constructed from enantiopure ami-
no acid residues, rather than elements of asymmetry in the
haptens.
In¢delity between haptens and the transition states that
they are intended to mimic [69] might also be expected to
lead to mature antibody combining sites that lack certain
functional groups that could enhance catalysis, and this is
exactly what is observed in many cases. However, func-
tionality not engineered through hapten design has also
been found to interact with elements of transition states.
For example, the increase in catalysis upon a⁄nity matu-
ration of antibody 48G7 can be largely explained by the
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interaction between the transition state and an additional
hydrogen bond acceptor (Tyr33H) upon maturation (see
Fig. 1) [25^29,69]. The presence of a hydrogen bond ac-
ceptor in a combining site elicited against a phosphonate
hapten with no hydrogen bond donor functionality is sur-
prising ^ in fact, this residue actually behaves as a hydro-
gen bond donor when 48G7 is bound to its phosphonate
hapten. These observations suggest that by displaying res-
idues that may switch between donor and acceptor roles,
the immune system again acquires increased diversity at
no genetic cost. One might also consider the presence of
active site nucleophilic residues, as found for antibodies
43C9 [51] and 7C8 [60], to be similarly serendipitous.
3. Summary
The available experimental and theoretical evidence sug-
gests that there is a direct connection between TSEs and
canonical binding arrays. Although a connection between
hapten structure and mature antibody combining sites is
not at all surprising ^ it is the very assumption upon which
the proposal of antibody catalysis was predicated [3] ^ the
connection between relatively small hapten substructures
and particular combining site residues is more intriguing
and of greater utility for catalyst engineering. According
to our model, the origins of this correspondence can be
traced to one or more of the following:
1. the presence of generic germline binders for particular
types of functionality
2. biological epitope mimicry
3. sampling of multiple antibody conformations
These principles provide new avenues for design by
chemists of ‘input’ that can be translated and expressed
by nature in architectures compatible with transition state
stabilization.
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